CELL & GENE THERAPY INSIGHTS

Spotlight

Foreword


Editorial


Expert Insight


Innovator Insight


Interview


Expert Roundtable Video

Expert Roundtable: evolution in AAV process development: 2022 and beyond

Alejandro Becerra,
Matthias Hebben,
Michael Mercaldi
11 October 2021
Expert Roundtable Video

Expert Roundtable: overcoming challenges in analytical assays for cellular therapies

Jara Joedicke,
Eric Alonzo, PhD,
Marsilius Mues
11 October 2021
Expert Roundtable Video

Expert Roundtable

Expert Roundtable: overcoming challenges in analytical assays for cellular therapies

Jara Joedicke,
Eric Alonzo, PhD,
Marsilius Mues
13 October 2021
Expert Roundtable

Expert Roundtable: evolution in AAV process development: 2022 and beyond

Alejandro Becerra,
Matthias Hebben,
Michael Mercaldi
12 October 2021
Expert Roundtable

FastFacts


Viewpoint


Supply Chain FOCUS

Interview


On Demand Webinar

Importance of high-quality starting material for success in advanced therapy

Bob Amareld,
Nathan Frank, MS,
Jason C Lin,
Richard McFarland,
John Paul Tomtishen III
12 August 2021
On Demand Webinar

Vectors FOCUS

Innovator Insight

Transfer and scale-up from 10 L BioBLU®️ to Allegro™ STR 50 and STR 200 Bioreactors

David Mainwaring,
Amar Joshi,
Juliana Coronel,
Christian Niehus
25 November 2021
Innovator Insight

Key considerations for maximizing LV and AAV production in transient transfection workflows

Leisha Kopp,
Beth Larimore,
Nolan Sutherland,
Anindya Dasgupta
8 October 2021
Innovator Insight

Utilizing a media panel rapidly accelerates media optimization for AAV manufacturers

Céline Martin,
Jennifer Zatina
28 September 2021
Innovator Insight

Scalability comparison between 50 and 500 liter stirred tank bioreactor for production of rAAV viral vector

Todd P Sanderson,
Timothy Erlandson,
Nathan Hazi,
Anne MacIntyre,
Benjamin I Ingersoll,
Michael McLaughlin,
Steven Wesel,
Phillip B Maples
23 September 2021
Innovator Insight

Evaluation of a microbioreactor system as a screening tool for optimizing lentiviral vector process development in suspension culture

Nolan Sutherland,
Lesley Chan,
Kelly Kral,
Franziska Bollmann
22 September 2021
Innovator Insight

Commentary


FastFacts


Viewpoint

Overview of major AAV production platforms

Jote Bulcha
24 September 2021
Viewpoint

Report

Other articles

Webinars

Cell-based therapies for cancer treatment: leveraging advanced flow cytometry for greater clinical insight

Cell-based therapies for cancer treatment: leveraging advanced flow cytometry for greater clinical insight

Nina Senutovitch Ph.D.
Nina Senutovitch Ph.D., Senior Scientist, Product Development, Cell Imaging, Sartorius
Professor Rong Fan
Professor Rong Fan, Professor of Biomedical Engineering, Yale University
Tamara J. Laskowski, Ph.D.
Tamara J. Laskowski, Ph.D., Scientific Project Director, Adoptive Cell Therapy Platform, Dept. of Stem Cell Transplantation and Cellular Therapy MD Anderson Cancer Center
5 August 2021
Webinar
Midstream unit operations: Unsung heroes in AAV process development

Midstream unit operations: Unsung heroes in AAV process development

Matthew Roach
Matthew Roach, AAV Process Development Team Leader, Precision BioSciences
Ratish Krishnan
Ratish Krishnan, Senior Strategy Consultant, Novel Modalities BioProcessing Group, Merck
18 August 2021
Webinar
The setup and payoff: entering the clinic and the market efficiently by leveraging a platform lentiviral vector process

The setup and payoff: entering the clinic and the market efficiently by leveraging a platform lentiviral vector process

Kevin D Beck, PhD
Kevin D Beck, PhD, Associate Director of Account Management, Miltenyi Biotec
1 September 2021
Webinar
AAV manufacturing with stable producer cells for industrial scale vector production

AAV manufacturing with stable producer cells for industrial scale vector production

Ben Hudjetz, PhD
Ben Hudjetz, PhD, Senior Scientist, Cell Line Development, CEVEC Pharmaceuticals GmbH
16 September 2021
Webinar
Get your non-viral T cell engineering process ready for clinical manufacturing

Get your non-viral T cell engineering process ready for clinical manufacturing

Melanie Rietenbach
Melanie Rietenbach, Global Product Manager Miltenyi Biotec
Stefan Wild
Stefan Wild, Senior Manager, Research and Development, Miltenyi Biotec
Kunal Patel
Kunal Patel, Process Engineering Manager, Miltenyi Biotec
21 September 2021
Webinar
GMP manufacturing for exosome-based therapies: the critical role of analytics and process design for clinical production and scale-up

GMP manufacturing for exosome-based therapies: the critical role of analytics and process design for clinical production and scale-up

Marcos Langtry
Marcos Langtry, Head of Allogeneic Cell Therapy Commercial Development, Lonza Pharma & Biotech
Davide Zocco
Davide Zocco, Research & Development Senior Manager, Lonza Pharma & Biotech
28 September 2021
Webinar
cGMP manufacturing made easy – a case study by ElevateBio

cGMP manufacturing made easy – a case study by ElevateBio

Michael Paglia
Michael Paglia, COO, ElevateBio, BaseCamp
Shannon Eaker
Shannon Eaker, Cell and Gene Therapy Enterprise Solutions and FastTrak Leader, Cytiva
14 October 2021
Webinar